COMMUNIQUÉS West-GlobeNewswire

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
25/06/2026
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102 regardless of age or disease severity Rett syndrome natural [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale
25/06/2026
Le Dr Gerd Zettlmeissl est nommé président du conseil d’administration Lyon (France), le 25 juin 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Valneva Announces Successful Outcome of its Annual General Meeting
25/06/2026
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that shareholders approved [...]
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
25/06/2026
New market insights identify misaligned operational priorities in digital health and outline a framework for unification SEATTLE, June 25, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and [...]
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
25/06/2026
New online guide explores NAD+, cellular energy production, and healthy aging research Regenix Labs logo. NEWARK, Del., June 25, 2026 (GLOBE NEWSWIRE) -- Regenix Labs LLC announces the availability of its educational [...]
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scale MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced [...]
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
25/06/2026
Alphonso Davies and Leylah Fernandez partnering with the Canadian Red Cross OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is pleased to announce Canadian men’s national soccer team captain Alphonso [...]
Deux athlètes d’élite du Canada deviennent ambassadeurs du programme de dons mensuels de la Croix-Rouge canadienne
25/06/2026
Alphonso Davies et Leylah Fernandez s’associent à la Croix-Rouge canadienne OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne est heureuse d’annoncer que la grande joueuse de tennis canadienne Leylah [...]
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
25/06/2026
Program provides employers simple, clinically governed GLP-1 management options regardless of plan coverage CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- First Stop Health, the connected, whole-person virtual care platform [...]
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
25/06/2026
Santa Rosa, United States, June 25, 2026 (GLOBE NEWSWIRE) -- Eliaz Therapeutics Announces Publication Highlighting Selective Galectin-3 Removal Approach in Sepsis and Advancement of XGAL-3 Development Program Company [...]
Milestone Scientific Strengthens Board to Support Next Phase of Growth
25/06/2026
Appoints Two Independent Directors with Deep Healthcare, Technology and Financial Expertise Chair of the Board Transitions to Executive Chair to Drive Strategic Execution ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE [...]
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
25/06/2026
Ninth Annual Program Honors the AI Innovators Shaping the Next Era of Global Innovation LONDON, June 25, 2026 (GLOBE NEWSWIRE) -- Evaluate , a Norstella company and the leading global provider of market insights for the [...]
Arrakis Therapeutics Announces CEO Transition with Mark DeLong Appointed as New CEO
25/06/2026
— Mark DeLong to lead Arrakis as it becomes a clinical-stage company, advancing its lead oral RNA-targeted small molecule to treat myotonic dystrophy type 1 (DM1) — — Michael Gilman retires from role of CEO following [...]
Aeroflow Health Acquires Canopie to Close the Maternal Care Gap for Millions of New Mothers
25/06/2026
ASHEVILLE, N.C., June 25, 2026 (GLOBE NEWSWIRE) -- In the ongoing development of its comprehensive maternal health platform, Aeroflow Health , a technology-enabled healthcare company serving millions of patients [...]
DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
25/06/2026
Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. ( [...]
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the [...]

Pages